Answers are grounded in this paper and cite their sources.
Combining standard therapy with GLP-1 receptor agonists offers superior efficacy in improving metabolic and hormonal outcomes in women with PCOS. Orlistat effectively reduces androgen levels. These findings support the use of combination pharmacotherapy for comprehensive management of PCOS.
No takes yet. Share an insight, caveat, or question.
Bo et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: